Fig. 1From: The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney diseaseSelection of Study Patients. GLP-1RA glucagon-like peptide 1 receptor agonist; DPP-4i dipeptidyl peptidase 4 inhibitor; DM diabetes mellitus; eGFR estimated glomerular filtration rateBack to article page